Onderneming Alcon, Inc.
Aandelen
ACL
CH0013826497
Medische apparatuur, benodigdheden & distributie
slotkoers
Andere beurzen
|
||
- USD | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 305 044 983 | 61 479 792 ( 20,15 %) | 2 654 717 ( 0,8703 %) | 20,15 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
ALCON INC. 1.29% | 6 438 707 | 1.29% | 507 627 660 $ |
Bedrijfsgegevens
Bedrijven van de groep
Naam | Categorie en sector |
---|---|
Alcon Laboratories (India) Pvt Ltd.
Alcon Laboratories (India) Pvt Ltd. Medical DistributorsDistribution Services Alcon Laboratories (India) Pvt Ltd. provides pharmaceutical products and services. The company is headquartered in Bangalore, India. |
Medical Distributors
|
Alcon Management SA
| |
Alcon Finance Corp.
Alcon Finance Corp. Finance/Rental/LeasingFinance Alcon Finance Corp.provides financing services. The company is headquartered in Delaware, United States. |
Finance/Rental/Leasing
|
Alcon Singapore Manufacturing Pte Ltd.
Alcon Singapore Manufacturing Pte Ltd. Pharmaceuticals: MajorHealth Technology Part of Alcon AG, Alcon Singapore Manufacturing Pte Ltd. is a company that engages in chemical preparations. The company is based in Singapore, Singapore. |
Pharmaceuticals: Major
|
Alcon Pharmaceuticals Ltd.
Alcon Pharmaceuticals Ltd. Medical SpecialtiesHealth Technology Alcon Pharmaceuticals Ltd. supplies pharmaceuticals products. The company is headquartered in Fribourg, Switzerland. |
Medical Specialties
|
Alcon Laboratories Belgium BVBA
Alcon Laboratories Belgium BVBA Pharmaceuticals: MajorHealth Technology Part of Alcon AG, Alcon Laboratories Belgium BV is a Belgian company that manufactures medicines. The company is located in Belgium. |
Pharmaceuticals: Major
|
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,17% | 45,32 mld. | |
-0,24% | 18,79 mld. | |
-22,28% | 2,17 mld. | |
+17,94% | 1,98 mld. | |
+20,05% | 1,14 mld. | |
-41,45% | 679 mln. | |
-7,76% | 667 mln. | |
-45,04% | 628 mln. | |
+56,94% | 605 mln. |